RxDoctor Payments Data

Elizabeth Lieberman, MD

Orthopaedic Surgery · Portland, ORNPI 1578982567

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $318,846 of the $352,843 with a category attached, or 90.4%. Zimmer Biomet accounts for 77.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $273,444, more than ten times the $498 reported in 2019. Among orthopaedic surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$352,843in general payments, 2019–2025

Across 239 payments — averaging $1476.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$275K
  • Medical Device Business Services, Inc.$54K
  • Depuy Synthes Products, Inc.$10K
  • Johnson & Johnson$5K
  • Averitas Pharma Inc.$3K
  • Smith+Nephew$2K
  • plus $4K from 8 others
$30,409in research payments, 2019–2025

Across 10 payments — averaging $3040.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$30K

What the payments were for

  • Consulting fees$318,84690%
  • Speaking & faculty fees$3,0001%
  • Travel & lodging$19,6426%
  • Food & beverage$9,9563%
  • Education$1,3990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$352,843 in reported general payments places this provider in the 95th percentile of 228 orthopaedic surgery providers in Oregon.

See all orthopaedic surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$243,868
Medicare patients
349
Services billed
2,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib104$1,428
Oxycodone Hcl182$1,215
Omeprazole67$772
Methocarbamol88$581
Meloxicam52$296
Ondansetron Hcl50$263
Gabapentin12$173
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$162
Cephalexin13$158
Ondansetron OdtOndansetron34$140
Amoxicillin31$117
Hydromorphone Hcl17$107
Methylprednisolone13$104
Tramadol Hcl23$98

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →